Диссертация (1173328), страница 23
Текст из файла (страница 23)
Schlembach et al. // Ultrasound in Obstetrics andGynecology. – 2015. – Vol. 45, №3. – P. 241-246.142143. Influencingfactorsforlate-onsetpreeclampsia/S.Ornaghi,A.Tyurmorezova, P. Algeri et al. // Journal of Maternal-Fetal NeonatalMedicine. – 2013. – Vol. 26, № 13. – P. 1299–1302.144. Integrated Proteomic and Metabolomic prediction of Term Preeclampsia / R.Bahado-Singh, L.C.
Poon, A. Yilmaz et al. // Scientific Reports. – 2017. –Vol. 7, № 1. – 16189.145. Integrated systems biology approach identifies novel maternal and placentalpathways of preeclampsia / N.G. Than, R. Romero, A.L. Tarca et al. //FrontiersinImmunology.–2018.–Режимдоступа:https://doi.org/10.3389/fimmu.2018.01661.146. Interpregnancy interval and maternal and perinatal outcome across LatinAmerica from 1990 to 2009: a large multi-country study / L.E. Mignini, G.Carroli, A.P.
Betrán et al. // BJOG. – 2016. – Vol. 123, № 5. – P. 730-737.147. Kayumova, L.H. Hemostasis under physiological and gestosis of pregnancy /L.H. Kayumova // Journal «Medical almanac». – 2009. – Vol. 4, № 9. – P.63-66.148. Kenny, L.C. Immunological tolerance, pregnancy and preeclampsia: the rolesof semen microbes and the father / L.C. Kenny, B.K. Douglas // Frontiers inMedicine.–2018.–Режимдоступа:https://doi.org/10.3389/fmed.2017.00239149. LeFevre, M.L.
Low-dose aspirin use for the prevention of morbidity andmortality from preeclampsia: U.S. Preventive Services Task Forcerecommendation statement / M.L. LeFevre, U.S. Preventive Services TaskForce // Annals of Internal Medicine. – 2014. – Vol. 161, № 11. – P. 819-826.150. Longitudinal evaluation of predictive value for preeclampsia of circulatingangiogenic factors through pregnancy / T.F. McElrath, K.H.
Lim, E. Pare etal. // American Journal of Obstetrics and Gynecology. – 2012. – № 207. –P. 407.151. Low soluble fms-like tyrosine kinase-1, endoglin, and endothelin-1 levels inwomen with confirmed or suspected preeclampsia using proton pump143inhibitors / L. Saleh, R. Samantar, I.M. Garrelds et al. // Hypertension.
–2017. – Vol. 70, № 3, P. 594-600.152. Markers of endothelial activation in preeclampsia / M. Prochazka, J.Prochάzkovά, M. Lubušký еt al. // Clinical Laboratory. – 2015. – Vol. 61,№ 1-2. – P. 39-46.153. Maternal age and risk for adverse outcomes / J.J. Sheen, J.D. Wright,D. Goffman et al. // American Journal of Obstetrics and Gynecology. – 2018.– Режим доступа: https://doi.org/10.1016/j.ajog.2018.08.034.154. Maternal hyperlipidemia and the risk of preeclampsia: a meta-analysis / C.N.Spracklen, C.J. Smith, A.F.
Saftlaset al. // American Journal of Epidemiology.– 2014. – Vol. 180. – P. 346-358.155. Maternal serum adiponectin at 11–13 weeks of gestation in preeclampsia /S. Nanda, C.K. Yu, L. Giurcaneanu et al. // Fetal Diagnosis and Therapy. –2011. – Vol. 29, № 3. – P. 208-215.156. Maternal serum PAPP-A and free β-hCG at 12, 22 and 32 weeks’ gestation inscreening for pre-eclampsia / F. Wright, L. Guerra, M. Pellegrino et al. //Ultrasound in Obstetrics and Gynecology.
– 2016, №. 47.– P.762-767.157. Matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 and 2as potential biomarkers for gestational hypertension / J. Ab Hamid, N.Mohtarrudin, M. Osman et al. // Singapore Medical Journal. – 2012. –Vol. 53, № 10. – P. 681-683.158. McDonald, E.A. The pro-inflammatory role of adiponectin at the maternalfetal interface / E.A. McDonald, M.W. Wolfe // American Journal ofReproductive Immunology. – 2011. – Vol. 66, № 2. – P. 128-136.159. Multicenters screening for preeclampsia by maternal factors and biomarkersat 11–13 weeks’ gestation: comparison to NICE guidelines and ACOGrecommendations / N. O’Gorman, D. Wright, L. Poon et al.
// Ultrasound inObstetrics and Gynecology. – 2017. – № 49. – P. 756-760.144160. Ni, Y. Comparison of indications of pregnancy termination and prognosis ofmothers and neonates in early- and late-onset preeclampsia / Y. Ni, W. Cheng// Hypertension in Pregnancy. – 2016. – Vol. 35, № 3. – P.
315-322.161. Obstetric behavior and pregnancy outcome in overweight and obese women /Meenakshi, R. Srivastava, N.R. Sharma et al. // The Journal of Obstetrics andGynecology of India. – 2012. – Vol. 62, № 3. – P. 276-280.162. Panaitescu, A.M. Chronic hypertension and adverse pregnancy outcome: acohort study / A.M. Panaitescu, A. Syngelaki, K.H. Nicolaides // Obstetricaland Gynecological Survey. – 2018. – Vol. 73, № 1.
– P. 7-8.163. Parental age and the risk of gestational hypertension and preeclampsia / C.Ortiz, N.U. Rondeau, L.E. Moore et al. // The Southern Medical Journal. –2018. – Vol. 111, № 9. – P. 544-548.164. Placental growth factor (PlGF) and sFlt-1 during pregnancy: physiology,assay and interest in preeclampsia / É. Lecarpentier, S. Vieillefosse, B.Haddad et al. // Annales de Biologie Clinique.
– 2016. – Vol. 74, №3. –P. 259-267.165. Plasma adiponectin concentration in early pregnancy and subsequent risk ofhypertensive disorders / R. DʼAnna, G. Baviera, F. Corrado et al. // Obstetrics& Gynecology. – 2005. – Vol. 106, № 2. – P. 340-344.166. Plasma levels of inflammatory markers neopterin, sialic acid, and C-reactiveprotein in pregnancy and preeclampsia / F.M. von Versen-Hoeynck, C.A.Hubel, M.J. Gallaher et al.
// American Journal of Hypertension. – 2009. –Vol. 22, №6. – P. 687-692.167. Poon, L.C. Early prediction of preeclampsia / L.C. Poon, K.H. Nicolaides //Obstetrics and Gynecology International. – 2014. – Vol. 2014. – 297397.168. Pourrat, O. ADAMTS-13 deficiency in severe postpartum HELLP syndrome /O.Pourrat, R. Coudroy, F. Pierre // British Journal of Haematology. – 2013.
–Vol. 163, №3. – P. 409-410.169. Prediction of early and late pre-eclampsia from maternal characteristics,uterine artery Doppler and markers of vasculogenesis during first trimester of145pregnancy / M. Parra-Cordero, R. Rodrigo, P. Barja et al. // Ultrasound inObstetrics and Gynecology. – 2013. – № 41. – P. 538-544.170. Prediction of preeclampsia in primigravida in late first trimester using serumplacental growth factor alone and by combination model / R. Agarwal, S.Chaudhary, R.
Kar et al. // Journal of Obstetrics and Gynaecology. – 2017. –Vol. 37, № 7. – P. 877-882.171. Predictive value of the sFlt-1: PlGF ratio in women with suspectedpreeclampsia / H. Zeisler, E. Llurba, F. Chantraine et al. // The New EnglandJournal of Medicine. – 2016. – Vol.
374. – P. 13-22.172. Pre-eclampsia and assisted reproductive technologies: consequences ofadvanced maternal age, interbirth intervals, new partner and smoking habits /A. Tandberg, K. Klungsoyr, L.B. Romundstad et al. // BJOG. – 2015. –Vol. 122. – P. 915–922.173. Preeclampsia and gestational weight gain in the Norwegian fit for deliverytrial / E.R. Hillesund, S.
Seland, E. Bere et al. // BMC Research Notes. –2018. – Vol. 11, № 1. – P. 282.174. Preeclampsia biomarkers: an assessment of maternal cardiometabolic health /G. Eastabrook, T. Aksoy, S. Bedell et al. // Pregnancy Hypertension. – 2018.– Vol. 13. – P. 204-213.175. Pre-eclampsia is associated with, and preceded by, hypertriglyceridaemia: ameta-analysis / I.D. Gallos, K. Sivakumar, M.D.
Kilby et al. // BJOG. – 2013.– Vol. 120, № 11. – P. 1321-1332.176. Pre-eclampsia part 1: current understanding of its pathophysiology / T.Chaiworapongsa, P. Chaemsaithong, L. Yeo et al. // Nature ReviewsNephrology. – 2014. – Vol. 10, № 8. – P. 466-480.177. Preeclampsia screening: evidence report and systematic review for the USPreventive Services Task Force / J.T. Henderson, J.H. Thompson, B.U. Burdaet. al // JAMA.
– 2017. –Vol. 317, № 16. – P. 1668-1683.178. Preeclampsia: an update / G. Lambert, J.F. Brichant, G. Hartstein et al. // ActaAnaesthesiologica Belgica. – 2014. – № 65. – P. 137-149.146179. Preeclampsia: pathophysiology, diagnosis, and management / J. Uzan, M.Carbonnel, O.
Piconne et al. // Vascular health and risk management. – 2011.– Vol. 7. – P. 467-474.180. Preeclampsia; short and long-term consequences for mother and neonate / A.Bokslag, M. van Weissenbruch, B.W. Mol et al. // Early HumanDevelopment. – 2016. – № 102. – P. 47-50.181. Pregnancy risk factors for very premature delivery: what role dohypertension, obesity and diabetes play? / J. Spiegler, G. Stichtenoth, J.Weichert et al. // Archives of Gynecology & Obstetrics.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
